Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
British Journal of Cancer
|
February 18, 2022
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples
Eleonora Loi, Cesare Zavattari, Alessandro Tommasi, et al.
British Journal of Cancer
|
September 25, 2023
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy
Andrea Pretta, Pina Ziranu, Riccardo Giampieri, et al.
The Oncologist
|
July 3, 2026
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study
Giuseppe Neola, Fabiano Flauto, Carmine Caso, et al.
British Journal of Cancer
|
November 28, 2024
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenon
Andrea Pretta, Pina Ziranu, Eleonora Perissinotto, et al.
Scientific Reports
|
November 6, 2022
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma
Margherita Rimini, Carles Fabregat-Franco, Valentina Burgio, et al.
Clinical & Experimental Metastasis
|
February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations
Michele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 1, 2022
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters
Margherita Rimini, Eleonora Loi, Carles Fabregat-Franco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 24, 2022
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma
Margherita Rimini, Teresa Macarulla, Valentina Burgio, et al.
Targeted Oncology
|
January 23, 2023
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients
Margherita Rimini, Carles Fabregat-Franco, Mara Persano, et al.
Cancers
|
May 17, 2020
Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer
Eleonora Lai, Nicole Liscia, Clelia Donisi, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
British Journal of Cancer
|
February 18, 2022
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples
Eleonora Loi, Cesare Zavattari, Alessandro Tommasi, et al.
British Journal of Cancer
|
September 25, 2023
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy
Andrea Pretta, Pina Ziranu, Riccardo Giampieri, et al.
The Oncologist
|
July 3, 2026
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study
Giuseppe Neola, Fabiano Flauto, Carmine Caso, et al.
British Journal of Cancer
|
November 28, 2024
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenon
Andrea Pretta, Pina Ziranu, Eleonora Perissinotto, et al.
Scientific Reports
|
November 6, 2022
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma
Margherita Rimini, Carles Fabregat-Franco, Valentina Burgio, et al.
Clinical & Experimental Metastasis
|
February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations
Michele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 1, 2022
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters
Margherita Rimini, Eleonora Loi, Carles Fabregat-Franco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 24, 2022
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma
Margherita Rimini, Teresa Macarulla, Valentina Burgio, et al.
Targeted Oncology
|
January 23, 2023
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients
Margherita Rimini, Carles Fabregat-Franco, Mara Persano, et al.
Cancers
|
May 17, 2020
Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer
Eleonora Lai, Nicole Liscia, Clelia Donisi, et al.
Page
of 8